Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma.
Johnson, Brett E
Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma. [electronic resource] - Science (New York, N.Y.) Jan 2014 - 189-193 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
1095-9203
10.1126/science.1239947 doi
Antineoplastic Agents, Alkylating--adverse effects
Brain--drug effects
Brain Neoplasms--drug therapy
DNA Helicases--genetics
DNA Mutational Analysis
Dacarbazine--adverse effects
Glioma--drug therapy
Humans
Mutagenesis--drug effects
Neoplasm Grading
Neoplasm Recurrence, Local--chemically induced
Nuclear Proteins--genetics
Proto-Oncogene Proteins B-raf--genetics
Proto-Oncogene Proteins c-akt--genetics
TOR Serine-Threonine Kinases--genetics
Temozolomide
Transcription Factors--genetics
Tumor Suppressor Protein p53--genetics
X-linked Nuclear Protein
Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma. [electronic resource] - Science (New York, N.Y.) Jan 2014 - 189-193 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
1095-9203
10.1126/science.1239947 doi
Antineoplastic Agents, Alkylating--adverse effects
Brain--drug effects
Brain Neoplasms--drug therapy
DNA Helicases--genetics
DNA Mutational Analysis
Dacarbazine--adverse effects
Glioma--drug therapy
Humans
Mutagenesis--drug effects
Neoplasm Grading
Neoplasm Recurrence, Local--chemically induced
Nuclear Proteins--genetics
Proto-Oncogene Proteins B-raf--genetics
Proto-Oncogene Proteins c-akt--genetics
TOR Serine-Threonine Kinases--genetics
Temozolomide
Transcription Factors--genetics
Tumor Suppressor Protein p53--genetics
X-linked Nuclear Protein